Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 436-690-9 | CAS number: 220727-26-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Oral LD50 (rat) > 2000 mg/kg bw
Dermal LD50 (rat) > 2000 mg/kg bw
Acute toxicity: Inhalation: waiver
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 04 May - 31 Jul 2001
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: RCC Ltd, Biotechnology and Animal Breeding Division, Füllinsdorf, Switzerland
- Age at study initiation: Males: 8 weeks, Females: 10 weeks
- Weight at study initiation: no data
- Fasting period before study: 16 - 20 hours
- Housing: In groups of 3 per sex in Makrolon type-4 cages with wire mesh tops and standardized softwood bedding (´Lignocel´ Schill AG, CH-4132 Muttenz/Switzerland).
- Diet: Pelleted standard Provimi Kliba 3422 rat maintenance diet, batch no. 07/00 (Provimi Kliba AG, CH-4303 Kaiseraugst/Switzerland) ad libitum. Results of analyses for contaminants are archived at RCC Ltd., Itingen.
- Water: Community tap-water, from Itingen ad libitum. Results of bacteriological, chemical and contaminant analyses are archived at RCC Ltd, Itingen.
- Acclimation period: Under laboratory conditions, after health examinations. Only animals without any visible signs of illness were used for the study.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3 °C
- Humidity (%): 30 - 70%
- Air changes (per hr): 10 - 15 air changes/hour
- Photoperiod (hrs dark / hrs light): 12 hours fluorescent light / 12 hours dark (light period between 6.00 and 18.00), music during the light period. - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 2 mL/kg bw
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 3
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: daily during acclimatization and at least once daily during days 1 - 15. Bodyweights on days 1 (pre-administration), 8 and 15. Clinical signs daily during acclimatization and at least four times (target times: approximately one, two, three and five hours) on test day 1 after the administration, depending on the occurrence of clinical signs of toxicity. At least once daily during days 2 - 15, depending on the occurrence of clinical signs of toxicity.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight - Statistics:
- No.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortalities occured during the study.
- Clinical signs:
- other: No clinical signs of toxicity were noted.
- Gross pathology:
- No macroscopic findings were observed.
- Interpretation of results:
- other: CLP criteria not met
- Conclusions:
- The median lethal dose of Y-15099 after single oral administration to rats of both sexes, observed over a period of 14 days is greater than 2000 mg/kg body weight.
- Executive summary:
In an acute oral toxicity GLP study according to OECD 423, one group of three male and three female HanBrl: WIST (SPF) rats was treated by oral gavage with Y-15099 at 2000 mg/kg body weight. The test item was applied undiluted in volume of 2 mL/kg bw. The animals were examined for clinical signs daily during the acclimatization period, four times during test day 1 and once daily during test days 2 – 15. Mortality and viability were recorded daily during the acclimatization period and together with clinical signs at the same time intervals on test day 1 and at least once daily on test days 2 – 15. Body weights were recorded on day 1 (prior to administration) and on days 8 and 15. On day 15 all animals were necropsied and examined macroscopically. All animals survived until the end of the study period. No clinical signs were evident during the course of the study. The body weight of the animals was within the range commonly recorded for this strain and age. No macroscopic findings were observed at necropsy.
The median lethal dose of Y-15099 after single oral administration to rats of both sexes, observed over a period of 14 days is greater than 2000 mg/kg body weight.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 02 May - 06 Aug 2001
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: RCC Ltd, Biotechnology & Animal Breeding Devision, Füllinsdorf, Switzerland
- Age at study initiation: Males: 9 weeks; Females: 12 weeks
- Weight at study initiation: no data
- Housing: During acclimatization in groups of 5 per sex in Makrolon Type-4 cages with standard softwood bedding. Individually in Makrolon Type-3 cages with standard softwood bedding (´Lignocel´, Schill AG, CH-4132 Muttenz) during treatment and observation.
- Diet: Pelleted standard Kliba 3433, batch no. 07/00 rat maintenance diet (Provimi Kliba AG, CH-4303 Kaiseraugst) available ad libitum. Results of analyses for contaminants are archived at RCC Ltd, Itingen.
- Water: Community tap water from Itingen, available ad libitum. Results of bacteriological, chemical and contaminant analyses are archived at RCC Ltd, Itingen.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3 °C
- Humidity (%): 30 - 70%
- Air changes (per hr): 10 - 15 air changes/hour
- Photoperiod (hrs dark / hrs light): 12 hours fluorescent light/12 hours dark (light period between 6.00 and 18.00), music during the light period. - Type of coverage:
- semiocclusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: backs of the animals
- % coverage: 10% of the body surface
- Type of wrap if used: wrap was fixed with elastic adhesive bandage
REMOVAL OF TEST SUBSTANCE
- Washing (if done): yes, with lukewarm tap water
- Time after start of exposure: 24 hours after application
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 2 mL
- Constant volume or concentration used: yes - Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: daily during acclimatization and at least one, two, three and approximately 5 hours after the test item administration, depending on the occurence of clinical signs of toxicity. At least once daily during days 2 - 15, depending on the occurence of clinical signs of toxicity. Bodyweights on days 1 (pre-administration), 8 and 15.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight - Statistics:
- No.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No deaths occured during the study.
- Clinical signs:
- other: No clinical signs of toxicity were observed.
- Gross pathology:
- No macroscopic findings were observed.
- Interpretation of results:
- other: CLP criteria not met
- Conclusions:
- The median lethal dose of Y-15099 after single dermal administration to rats of both sexes, observed over a period of 14 days is greater than 2000 mg/kg body weight.
- Executive summary:
In an acute dermal toxicity GLP study according to OECD 402, groups of five male and five female Hanlbm: WIST (SPF) rats were treated with Y-15099 at 2000 mg/kg bw by dermal application under semi-occlusive conditions (Damme, 2001). The test item was applied undiluted as delivered from the sponsor at a volume of 2 mL/kg bw. The animals were examined for clinical signs four times during the test day 1 and once daily during test days 2 – 15. Mortality/viability was recorded together with clinical signs at the same time intervals on test day 1. During test days 2 – 15 it was recorded two times a day. Body weights were recorded on day 1 prior to administration and on days 8 and 15. On day 15 all animals were euthanized and examined macroscopically. No deaths occurred during the study. No clinical signs of toxicity were observed during the observation period. The body weight of the animals was within the range commonly recorded for this strain and age. No macroscopic findings were observed at necropsy.
The median lethal dose of Y-15099 after single dermal administration to rats of both sexes, observed over a period of 14 days is greater than 2000 mg/kg body weight.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
Acute oral toxicity:
In an acute oral toxicity GLP study according to OECD 423, one group of three male and three female HanBrl:WIST (SPF) rats was treated by oral gavage with Y-15099 at 2000 mg/kg bw (Damme, 2001). The test item was applied undiluted in a volume of 2 mL/kg bw. The observation period was 15 days. All animals survived until the end of the study period. No clinical signs were evident during the course of the study. The body weight of the animals was within the range commonly recorded for this strain and age. No macroscopic findings were observed at necropsy. The acute oral LD50 was found to be greater than 2000 mg/kg bw.
Acute dermal toxicity:
In an acute dermal toxicity GLP study according to OECD 402, groups of five male and five female Hanlbm:WIST (SPF) rats were treated with undiluted Y-15099 at 2000 mg/kg bw by dermal application under semi-occlusive conditions (Damme, 2001). The exposure duration was 24 hours. The animals were observed for 15 days. No deaths occurred during the study. No clinical signs of toxicity and no macroscopic pathological changes were observed. The acute dermal LD50 was found to be greater than 2000 mg/kg bw.
Acute inhalation toxicity:
According to REGULATION (EC) No 1907/2006, Annex VIII, Section 8.5.2, Column 2, testing by the inhalation route is appropriate if exposure of humans via inhalation is likely taking into account the vapour pressure of the substance and/or the possibility of exposure to aerosols, particles or droplets of an inhalable size. The vapour pressure of the liquid substance is very low (0.002 Pa at 25 °C).Exposure to vapour can thus be precluded. Exposure to droplets is not given for the determined uses of the substance.
Justification for classification or non-classification
The inhalation route was judged to be a non-relevant route of exposure.
According to CLP (1272/2008/EC) classification criteria for acute toxicity, no classification is warranted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.